Kurt Karst: FDA does a poor job of getting info to the public

The Food and Drug Administration has a special, streamlined process for approving generics. Trouble is, the public announcements of FDA's decisions often get bo...

Kurt Karst, director, Hyman, Phelps and McNamara

The Food and Drug Administration has a special, streamlined process for approving generics. Trouble is, the public announcements of FDA's decisions often get bottled up. Attorney Kurt Karst, a director at Hyman, Phelps and McNamara, tells Federal Drive with Tom Temin that irritates and frustrates everyone, including drug companies, investors, federal judges and the public.

 

Copyright © 2024 Federal News Network. All rights reserved. This website is not intended for users located within the European Economic Area.

Related Stories